Li Puma Andrea, Passarelli Federica, De Lorenzis Elisa, Montanari Emanuele, Albo Giancarlo, Boeri Luca
Department of Urology, IRCCS Fondazione Ca' Granda, Policlinico di Milano, Milan, Italy.
Department of Clinical Sciences and Community Health, Department of Excellence, University of Milan, Milan, 2023-2027, Italy.
Urolithiasis. 2025 Jun 4;53(1):107. doi: 10.1007/s00240-025-01775-4.
To investigate complication rates, stone growth and passage according to residual fragments (RFs) size in a cohort of patients treated with miniPCNL (mPCNL). We retrospectively analysed data from 572 patients who underwent mPCNL between 01/2018 and 11/2023. We identified 105 (19.4%) patients with RFs and at least 1-year follow up. Demographics and RFs passage, regrowth and complications were recorded by chart review and phone interviews. RFs were stratified into ≤ 5 mm; 6-9 mm and ≥ 10 mm groups. Descriptive statistics and logistic regression models were applied to test the association between RFs size and stone related events. Median number and diameter of RFs were 2 (1-3) and 8 (5-10) mm, respectively. RFs of ≤ 5 mm (Group 1), 6-9 mm (Group 2) and ≥ 10 mm (Group 3) were detected in 27 (25.7%), 47 (44.7%) and 31 (29.6%) cases, respectively, after mPCNL. Overall, 23 (21.9%), 20 (19%) and 9 (8.5%) patients had a stone related event [emergency room (ER) admission], stone growth and passage during follow up, respectively. Renal colic requiring ER admission were more frequent in Group 2 compared to the ≥ 10 and ≤ 5 mm one (36.1% vs. 9.6% vs. 11.1%, p = 0.01). Conversely, Group 1 showed higher rates of stone growth compared to the other groups (37.0% vs. 17.0% vs. 6.4%, p = 0.02). No difference in the rate of UTIs and stone passage was reported according to RFs size. Multivariable logistic regression analysis showed that RFs of 6-9 mm had higher risk of stone related events (OR 5.5, p = 0.04) compared to the other groups, even after adjusting for patients' BMI. Conversely, patients with RFs ≤ 5 mm had higher risk of stone growth (OR 9.6, p = 0.04), compared to the other RFs groups, after adjusting for patients' BMI. RFs after mPCNL have different impact on patient's clinical course, according to their size. Large RFs are less likely to grow or cause stone-related events. Conversely, RFs of medium size (6-9 mm) are associated with higher risk of ER admission and should be promptly treated. Small RFs can increase in size, but conservative management or delayed surgery may be considered, as they typically remain asymptomatic during follow-up.
为了在一组接受微创经皮肾镜取石术(mPCNL)治疗的患者中,根据残留碎片(RFs)大小研究并发症发生率、结石生长及排出情况。我们回顾性分析了2018年1月至2023年11月期间接受mPCNL治疗的572例患者的数据。我们确定了105例(19.4%)有RFs且至少随访1年的患者。通过病历审查和电话访谈记录人口统计学资料以及RFs的排出、再生长和并发症情况。RFs被分为≤5mm;6 - 9mm和≥10mm组。应用描述性统计和逻辑回归模型来检验RFs大小与结石相关事件之间的关联。RFs的中位数数量和直径分别为2(1 - 3)个和8(5 - 10)mm。mPCNL术后,分别在27例(25.7%)、47例(44.7%)和31例(29.6%)病例中检测到≤5mm(第1组)、6 - 9mm(第2组)和≥10mm(第3组)的RFs。总体而言,分别有23例(21.9%)、20例(19%)和9例(8.5%)患者在随访期间发生了结石相关事件[急诊室(ER)入院]、结石生长和结石排出。与≥10mm组和≤5mm组相比,第2组因肾绞痛需要ER入院的情况更频繁(36.1%对9.6%对11.1%,p = 0.01)。相反,与其他组相比,第1组的结石生长率更高(37.0%对17.0%对6.4%,p = 0.02)。根据RFs大小,未报告尿路感染率和结石排出率的差异。多变量逻辑回归分析显示,即使在调整患者体重指数后,与其他组相比,6 - 9mm的RFs发生结石相关事件的风险更高(OR 5.5,p = 0.04)。相反,在调整患者体重指数后,与其他RFs组相比,RFs≤5mm的患者结石生长风险更高(OR 9.6,p = 0.04)。mPCNL术后的RFs根据其大小对患者的临床病程有不同影响。大的RFs生长或引起结石相关事件的可能性较小。相反,中等大小(6 - 9mm)的RFs与ER入院风险较高相关,应及时治疗。小的RFs可能会增大,但由于它们在随访期间通常无症状,可考虑保守治疗或延迟手术。